News | October 16, 2025
IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
EDQM has also issued a Certificate of Suitability for Allopurino
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
This will be an added advantage for Supriya Lifescience Limited in the European market.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
As official healthcare partner, ShardaCare deployed dedicated medical teams, emergency services, and on-site healthcare infrastructure
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
